Results
Treatment with ramipril resulted in the following risk reductions:
- 25% (p=0.0004) for combined primary outcome
- 22% for MI
- 33% for stroke
- 37% for cardiovascular death
- 17% revascularisation
- 24% (p=0.027) for overt nephropathy
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.